Results 141 to 150 of about 139,558 (270)

Should We Embrace New Drugs with Open Arms? Experience from a Community-Based, Open-Arm, Randomized Clinical Trial of Combination Antiretroviral Therapy in Advanced HIV Disease

, 1996
Julio Montaner, Robert S. Hogg, Leila F. Srour, Carol Murphy, Clayton G. Barber, Peter Phillips, Michael V. O’Shaughnessy, Martin T. Schechter   +7 more
openalex   +1 more source

Epidemiological impact and cost‐effectiveness analysis of PrEP provision expansion among MSM in the Netherlands

Journal of the International AIDS Society, Volume 28, Issue 6, June 2025.
Abstract Introduction Several European countries show potential for pre‐exposure prophylaxis (PrEP) provision expansion, with many men who have sex with men (MSM) on waiting lists. In the Netherlands, approximately 15,000 PrEP‐eligible/intending MSM are awaiting PrEP access.
Haoyi Wang, Stephanie Popping, David van de Vijver, Kai J. Jonas   +3 more
wiley   +1 more source

The miRNomics of antiretroviral therapy-induced obesity. [PDF]

Funct Integr Genomics
Majumdar N, Pokharel BR, Dickerson A, Cruceanu A, Rajput S, Pokhrel LR, Cook PP, Akula SM.   +7 more
europepmc   +1 more source

HIV drug resistance, early treatment outcomes and impact of guidelines compliance after protease inhibitor‐based second‐line failure in a dedicated resistance clinic in western Kenya: a retrospective cohort study

Journal of the International AIDS Society, Volume 28, Issue 6, June 2025.
Abstract Introduction Data on drug resistance, viral outcomes and guidelines compliance following protease inhibitor (PI)‐based second‐line failure in low‐ and middle‐income countries are limited, particularly in the era of dolutegravir‐containing antiretroviral therapy (ART). Methods We conducted a retrospective cohort study of people living with HIV (
John M. Humphrey, Shamim M. Ali, Allison DeLong, Vlad Novitsky, Edwin Sang, Bilal Jawed, Emmanuel Kemboi, Celia Ngetich, Suzanne Goodrich, Adrian Gardner, Joseph W. Hogan, Rami Kantor   +11 more
wiley   +1 more source

Depression and Its Predictors in Adults Receiving Antiretroviral Therapy. [PDF]

Cureus
Lebimoyo AA, Sanni M, Hassan MA.
europepmc   +1 more source

Immuno-activation with anti-CD3 and recombinant human IL-2 in HIV-1-infected patients on potent antiretroviral therapy

, 1999
Jan M. Prins, Suzanne Jurriaans, Rieneke M. E. van Praag, Hetty Blaak, Ronald P. van Rij, Peter Th.A. Schellekens, Ineke J. M. ten Berge, Si‐La Yong, Cecil H. Fox, Marijke Roos, Frank de Wolf, Jaap Goudsmit, Hanneke Schuitemaker, Joep M. A. Lange   +13 more
openalex   +1 more source

An ethical dilemma: availability of antiretroviral therapy after clinical trials with hiv infected patients are ended [PDF]

, 1997
Peter Cleaton‐Jones
openalex   +1 more source

REPRIEVE final results: What does it mean for guidelines in low‐ and middle‐income countries?

Journal of the International AIDS Society, Volume 28, Issue 6, June 2025.
Abstract Introduction The REPRIEVE study demonstrated significant reductions in major adverse cardiovascular events (MACE) with pitavastatin among people living with HIV (PWH) with low to moderate cardiovascular risk. Most MACE events occurred in higher‐income countries, raising important considerations for similar primary prevention interventions ...
Simiso Sokhela, Jennifer M. Manne‐Goehler, Samanta Lalla‐Edward, Mark J. Siedner, Mohammed K. Ali, Andrew Hill, Aaloke Mody, Anton Pozniak, Jeremy Nel, W. D. Francois Venter   +9 more
wiley   +1 more source

Influence of antiretroviral therapy on frailty among people living with HIV. [PDF]

Sci Rep
Contreras Macías E, Robustillo Cortés MLA, Morillo Verdugo R.   +2 more
europepmc   +1 more source

Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease

, 1998
Christophe Piketty, Philippe Castiel, Laurent Bélec, Dominique Batisse, Ali Si Mohamed, Jacques Gilquin, Gustavo Gonzalez-Canali, D Jayle, Marina Karmochkine, Laurence Weiss, Jean Pierre Aboulker, Michel D. Kazatchkine   +11 more
openalex   +1 more source